What is IRIX's market cap?

$12.74M, based on the Nov 2 close of $0.73.

Does Iridex pay a dividend?

No regular cash dividend has been paid in the last year.

How much of IRIX is sold short?

76.2K shares, 0.6% of float, as of Oct 15, 2026.

What sector is IRIX in?

Healthcare, in the Electromedical Equipment industry.

NASDAQ · IRIXHealthcareElectromedical Equipment

Iridex Corp (IRIX)

$0.7254+1.90%

Close Nov 2, 2026 · split-adjusted

Oct 30, 2026$0.71▼ 32.20% in range

Oct 31, 2025Low $0.61 · High $1.56Oct 30, 2026

What changed · written from our data

As of Nov 2, 2026

Iridex closed at $0.73 on Nov 2, up 1.90%, 53.5% below its 52-week closing high. Volume of 10.2K shares was 0.01× its 20-day average (below normal).

Split-adjusted performance: +12.8% over one month, -33.1% over six months, -31.6% over one year.

In the quarter ended Jul 4, 2026, revenue was $12.57M, down 7.4% from a year earlier, with a net margin of -10.1%.

Short interest was 76.2K shares at the Oct 15 settlement, down 42.1% from the prior report (0.6% of float, 1.0 days to cover).

Market cap$12.7M17.6M shares

Revenue · quarter$12.6M−7.4% YoY

Diluted EPS$-0.07—

P/E · TTM—P/S 0.2×

Net margin-10.1%Gross 34.2%

Dividend yieldNone

52-week range0.61 – 1.56−53.5% from high

Volume10.2K0.01× 20-day avg

Volatility · 60d78.6%Annualised

Short % of float0.6%1.0 days to cover

Net cash$885.0KCash $4.7M

Next earnings—Not scheduled

Split-adjusted performance

1W −3.8%1M +12.8%3M −11.6%6M −33.1%YTD −36.4%1Y −31.6%3Y −75.1%5Y −90.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum29

Revenue growth12

Net margin58

Value (low P/E)—

Size14

Industry medians: 6-month return −5.0%, revenue growth +13.9%, net margin −44.6%, P/E 21.5×.

Short interest

Details →

Shares short76.2K−42.1% vs prior

Days to cover1.0Settled Oct 15

% of float0.6%

Short vol. 10d26.7%of daily volume

Closest peers by size in Electromedical Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
IRIXIridex	$0.7254	+1.90%	−33.1%	−7.4%	−10.1%	—	$12.7M
NDRAENDRA Life Sciences	$4.74	−0.21%	−4.0%	—	—	—	$7.1M	Compare
QTIQT Imaging Holdings	$2.21	+3.04%	−66.2%	+103.2%	−148.9%	—	$32.3M	Compare
STEXStreamex	$0.3790	−2.40%	−62.7%	—	−9968.5%	—	$44.1M	Compare
POCIPrecision Optics	$4.68	+0.54%	+10.5%	+42.0%	−1.2%	—	$51.4M	Compare
ECORelectroCore	$7.36	−2.13%	+10.2%	+28.0%	−32.4%	—	$66.4M	Compare
NUWENuwellis	$5.46	−3.96%	−98.5%	+14.1%	−245.1%	—	$2.2M	Compare
HYPRHyperfine	$0.7240	+0.89%	−60.0%	+44.8%	−238.2%	—	$76.8M	Compare
OMOutset Medical	$4.10	+1.74%	−5.3%	+0.7%	−56.8%	—	$77.1M	Compare

News about Iridex

All news →

Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced GlaucomaGlobeNewswire Inc. · Oct 12, 2026▲ Positive

Quick answers

What does Iridex do?: IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products.
What is IRIX's market cap?: $12.74M, based on the Nov 2 close of $0.73.
Does Iridex pay a dividend?: No regular cash dividend has been paid in the last year.
How much of IRIX is sold short?: 76.2K shares, 0.6% of float, as of Oct 15, 2026.
What sector is IRIX in?: Healthcare, in the Electromedical Equipment industry.

About Iridex

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

HQ: Mountain View, CA108 employeesListed Feb 16, 1996iridex.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology